相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
Norbert Kovacs et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up
K. Ray Chaudhuri et al.
JOURNAL OF PARKINSONS DISEASE (2022)
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
David G. Standaert et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
Francesc Valldeoriola et al.
NPJ PARKINSONS DISEASE (2021)
Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study
Alfonso Fasano et al.
MOVEMENT DISORDERS (2021)
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review
Angelo Antonini et al.
ADVANCES IN THERAPY (2021)
Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial
Eric Freire-Alvarez et al.
MOVEMENT DISORDERS (2021)
Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach
Zachary A. Macchi et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale
Attila Makkos et al.
PARKINSONISM & RELATED DISORDERS (2019)
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study
Leonardo Lopiano et al.
JOURNAL OF NEUROLOGY (2019)
Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States
Fahd Amjad et al.
ADVANCES IN THERAPY (2019)
Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
Werner Poewe et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel
K. Ray Chaudhuri et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Levodopa: A New Look at An Old Friend
C. Warren Olanow et al.
MOVEMENT DISORDERS (2018)
Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers
Rosella Ciurleo et al.
JOURNAL OF NEUROLOGY (2018)
Long-Term Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2018)
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
K. Ray Chaudhuri et al.
MOVEMENT DISORDERS (2018)
Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients
Marios Politis et al.
MOVEMENT DISORDERS (2017)
Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
Krisztina Horvath et al.
NEUROEPIDEMIOLOGY (2017)
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
Ahmed A. Othman et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion
Oriol De Fabregues et al.
BRAIN AND BEHAVIOR (2017)
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease
David G. Standaert et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients
Rejko Krueger et al.
ADVANCES IN THERAPY (2017)
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment
A. Merola et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
Angelo Antonini et al.
MOVEMENT DISORDERS (2016)
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2015)
Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients
John T. Slevin et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease
Maria T. Caceres-Redondo et al.
JOURNAL OF NEUROLOGY (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
K. Ray Chaudhuri et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Neuropathy and Levodopa in Parkinson's Disease: Evidence From a Multicenter Study
Roberto Ceravolo et al.
MOVEMENT DISORDERS (2013)
Which dyskinesia scale best detects treatment response?
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2013)
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
J. Kuisevsky et al.
NEUROLOGIA (2013)
Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden
D. Santos-Garcia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Determination of Minimal Clinically Important Change in Early and Advanced Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2011)
Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease
Angelo Antonini et al.
CNS DRUGS (2010)
Intrajejunal Levodopa Infusion in Parkinson's Disease: A Pilot Multicenter Study of Effects on Nonmotor Symptoms and Quality of Life
Holger Honig et al.
MOVEMENT DISORDERS (2009)
International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease
P. Martinez-Martin et al.
NEUROLOGY (2009)
Levodopa-related motor complications - Phenomenology
Susan H. Fox et al.
MOVEMENT DISORDERS (2008)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Predictors of weight loss in Parkinson's disease
Ergun Y. Uc et al.
MOVEMENT DISORDERS (2006)
分享论文
